Latest News

  • Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting Read More
  • Journal of Clinical Psychiatry Publishes Data from Alkermes' ALPINE Study in Patients With Schizophrenia Read More
  • Statement from Alkermes on Response to COVID-19 Read More

Investors

Working at Alkermes